| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Inhalation Products for the Management of Cystic Fibrosis | 2024-07-29 |
| BCBS Highmark NY and West NY | Naltrexone for Treatment of Alcohol and Opioid Dependence | 2024-07-29 |
| BCBS Highmark Delaware | Inhalation Products for the Management of Cystic Fibrosis | 2024-07-29 |
| BCBS Highmark West Virginia | Naltrexone for Treatment of Alcohol and Opioid Dependence | 2024-07-29 |
| BCBS Highmark West Virginia | Inhalation Products for the Management of Cystic Fibrosis | 2024-07-29 |
| BCBS Kansas | Extracranial Carotid Artery Stenting | 2024-07-27 |
| BCBS Kansas | Implantable Cardioverter Defibrillators | 2024-07-27 |
| BCBS Kansas | Extracranial Carotid Artery Stenting | 2024-07-27 |
| Aetna | Rozanolixizumab-noli (Rystiggo) | 2024-07-26 |
| Medicare WPS | Billing and Coding: MolDX: FDA-Approved KRAS Tests (55162) | 2024-07-24 |